companion diagnostics
| 3 min read
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker
| 3 min read
The new diagnostic enables rapid identification of acute leukaemia patients with KMT2A rearrangements for precision therapy.
| 4 min read
A well-chosen CDx development partner can streamline drug development, reduce delays, and pave the way for successful regulatory approval and market entry.
| 2 min read
INOVIO, QIAGEN expand their existing collaboration to cover companion diagnostics for INVOIO's HPV therapies
Page 1 of 1 - 4 Total Items
